neurocare group

neurocare group is the developer of a Digital Therapeutics Platform (DTP) designed to enable clinicians to deliver best practices. The company provides comprehensive psychosomatic intake, assisting clinicians in creating personalized treatment plans that lead to sustainable outcomes by enhancing clients' self-regulation, resilience, and social skills. The company plans to integrate CBT (Cognitive Behavioral Therapy), neuromodulation (such as rTMS for treating depression), or medications (such as novel psychedelics), based on natural learning ability (neuroplasticity).